Idorsia Shares Evidence in Citizen Petition to De-Schedule D

The petition with the US DEA is aiming to remove dual orexin receptor antagonist medications from the Controlled Substances Act due to negligible potential for abuse.

Related Keywords

United States , Switzerland , Swiss , American , Vaughn Mccall , Jean Paul Clozel , Health Behavior At Augusta University , Drug Administration , Idorsia Pharmaceuticals , Department Of Psychiatry , Drug Enforcement Administration , Citizen Petition , Paul Clozel , Chief Executive Officer , Controlled Substances , Controlled Substances Act , Case Distinguished Chair , Health Behavior , Augusta University , Files Petition , Purging Them , De Schedule Dual Orexin Receptor Antagonist Class ,